Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura,Hemiplegic Migraine,and Retinal Migraine

Abstract

Background:

Migraines are a broad spectrum of disorders classified by the type of aura with some requiring attentive treatment. Vasoconstrictors, including triptans, should be avoided in the acute phase of migraines with brainstem aura, in hemiplegic migraine, and in retinal migraine. This study investigated the characteristics and burden of these migraines.

Methods:

Medical charts of 278 Japanese pediatric patients with migraines were retrospectively reviewed. Migraine burden of migraines with brainstem aura, hemiplegic migraines, and retinal migraine was assessed using the Headache Impact Test-6™ (HIT-6) and the Pediatric Migraine Disability Assessment scale (PedMIDAS).

Results:

Of 278 patients screened, 12 (4.3%) patients with migraines with brainstem aura (n = 5), hemiplegic migraines (n = 2), and retinal migraine (n = 5) were enrolled in the study. All patients had migraine with/without typical aura, whereas some patients had coexisting migraine with another type of headache (chronic tension-type headache in 3 patients, and 1 each with frequent episodic tension-type headache, headache owing to medication overuse, and chronic migraine). Migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients with coexisting headaches had higher HIT-6 or PedMIDAS scores, whereas migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients without coexisting headache did not show high HIT-6 or PedMIDAS scores.

Conclusion:

All migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients experienced migraine with or without typical aura, and some patients having other coexisting headaches also had high PedMIDAS and HIT-6 scores. PedMIDAS and HIT-6 should not be considered diagnostic indicators of migraines with brainstem aura, hemiplegic migraines, or retinal migraine. In clinical practice for headaches in children, careful history taking and proactive assessment of the aura are needed for accurate diagnosis of migraines with brainstem aura, hemiplegic migraines, and retinal migraine.

Keywords

migraine variants triptan migraine with brainstem aura hemiplegic migraine retinal migraine International Classification of Headache Disorders-3

Get full access to this article

View all access options for this article.

References

Ayatollahi

Khosravi

. Prevalence of migraine and tension-type headache in primary-school children in Shiraz. East Mediterr Health J. 2006;12(6):809–817.

Ando

Fujimoto

Ishikawa

, et al. Prevalence and features of migraine in Japanese junior high school students aged 12-15 yr. Brain Dev. 2007;29(8):482–485.

Goto

Yokoyama

Nozaki

, et al. Characteristics of headaches in Japanese elementary and junior high school students: a school-based questionnaire survey. Brain Dev. 2017;39(9):791–798.

Laurell

Larsson

Eeg-Olofsson

. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia. 2004;24(5): 380–388.

Pacheva

Ivanov

. Migraine variants—occurrence in pediatric neurology practice. Clin Neurol Neurosurg. 2013;115(9):1775–1783.

Grosberg

Solomon

Lipton

. Retinal migraine. Curr Pain Headache Rep. 2005;9(4):268–271.

Patniyot

Gelfand

. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016;56(1):49–70.

Burger

Saul

Selhorst

Thurston

. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325(12):870–873.

Jehn

Frank Dettwiler

Fleischhauer

Sturzenegger

Mojon

. Exercise-induced vasospastic amaurosis fugax. Arch Ophthalmol. 2002;120(2):220–222.

10.

Winterkorn

Kupersmith

Wirtschafter

Forman

. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329(6):396–398.

11.

Headache Classification Committee of the International Headache S. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.

12.

Kosinski

Bayliss

Bjorner

, et al. A six-item Short-Form Survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12(8):963–974.

13.

Hershey

Powers

Vockell

LeCates

Kabbouche

Maynard

. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57(11):2034–2039.

14.

Limmroth

May

Auerbach

Wosnitza

Eppe

Diener

. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138(1-2):60–65.

15.

Totaro

De Matteis

Marini

Baldassarre

Carolei

. Sumatriptan and cerebral blood flow velocity changes during migraine attacks. Headache. 1997;37(10):635–639.

16.

Klapper

Mathew

Nett

. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache. 2001;41(10):981–984.

17.

Artto

Nissila

Wessman

Palotie

Farkkila

Kallela

. Treatment of hemiplegic migraine with triptans. Eur J Neurol. 2007;14(9):1053–1056.

18.

Russell

Ducros

. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457–470.

19.

Demarquay

Ducros

Montavont

Mauguiere

. Migraine with brainstem aura: why not a cortical origin? Cephalalgia. 2017;38(10):1687–1695.

20.

Moskowitz

Bolay

Dalkara

. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol. 2004;55(2):276–280.

21.

Silberstein

Dodick

. Migraine genetics: part II. Headache. 2013;53(8):1218–1229.

22.

Iizuka

Takahashi

Sato

, et al. Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry. 2012;83(2):205–212.

23.

Koyano

Konishi

Okada

Kusaka

Itoh

. Changes in (99 m)Tc-ECD SPECT and magnetic resonance angiography with sporadic hemiplegic migraine in a child. Clin Nucl Med. 2014;39(5):483–484.

24.

Mathew

Krel

Buddhdev

, et al. A retrospective analysis of triptan and DHE use for basilar and hemiplegic migraine. Headache. 2016;56(5):841–848.

25.

Oskoui

Pringsheim

Holler-Managan

, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Headache. 2019;59(8):1158–1173.

26.

Sauro

Rose

Becker

, et al. HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 2010;50(3):383–395.

27.

Sampaio Rocha-Filho

Hershey

. Pediatric Migraine Disability Assessment (PedMIDAS): translation into Brazilian Portuguese and cross-cultural adaptation. Headache. 2017;57(9):1409–1415.